#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary hypertension B-cell lymphoma Fallopian tube cancer Neuroendocrine carcinoma metastatic Familial hypertriglyceridaemia Ocular myasthenia Congenital nephrogenic diabetes insipidus Loss of consciousness Biotinidase deficiency Adenomatous polyposis coli Hypergammaglobulinaemia benign monoclonal Stevens-Johnson syndrome Anti-glomerular basement membrane disease Retinopathy proliferative Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma metastatic Basal cell naevus syndrome – Trials in Disease Urea cycle disorder – Trials in Disease Usher’s syndrome – Life with Disease Leiomyosarcoma – Diagnostics Leiomyosarcoma recurrent – Diagnostics Bronchopulmonary dysplasia – Treatment Crigler-Najjar syndrome Lennox-Gastaut syndrome – Life with Disease Hepatoblastoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dazucorilant ZAMPILIMAB Ripretinib Gs-5718-03 Amg 193 Dolutegravir IDROXIOLEIC ACID Phenobarbital Dexamethasone Fexofenadine Hydrochloride Zenocutuzumab Ltp001 Inupadenant Hydrochloride ULIXERTINIB Sulfamethizole Bemnifosbuvir Hemisulfate Permethrin Fadraciclib 2-DEOXY-D-GLUCOSE Opelconazole More therapies…

    Learn about Your Condition

    Schizoaffective disorder Elderly Hip fracture Familial mediterranean fever T-cell type acute leukaemia Marginal zone lymphoma Type 1 diabetes mellitus Extra-osseous Ewing's sarcoma Appendicitis Amyotrophic lateral sclerosis Rubella Joint stabilisation Intermittent claudication Triple positive breast cancer Cardiac amyloidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial prostatitis

  • Study on the Effectiveness of Fosfomycin, Cefixime, and Ciprofloxacin in Treating Acute Bacterial Prostatitis in Adult Men

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial prostatitis
    Investigated Drugs:
    • Cefixime
    • Fosfomycin
    • Ciprofloxacin Hydrochloride
    Spain
  • Short-course (7‑day) versus standard 14‑day ciprofloxacin treatment for men with serious urinary tract infection

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bacterial prostatitis
    • Pyelonephritis acute
    • Urinary tract infection
    Investigated Drugs:
    • Ciprofloxacin
    Belgium
  • Study on Fosfomycin for Treating Acute Bacterial Prostatitis in Patients with Multidrug-Resistant E. coli

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial prostatitis
    • Prostatitis Escherichia coli
    Investigated Drugs:
    • Fosfomycin
    Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!